EGF Theramed Health Income Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cost of Revenue	-	-	0	-	-	0.11
Gross Profit	-	-	-0	-	-	-0.11
Selling, General & Admin	0.22	0.26	0.23	0.35	0.97	0.69
Operating Expenses	0.22	0.26	0.23	0.35	0.97	0.76
Operating Income	-0.22	-0.26	-0.23	-0.35	-0.97	-0.87
Interest Expense	-0.08	-0.07	-0.06	-0.04	-0.01	-0.37
Interest & Investment Income	-	-	0.02	-	0	0
Currency Exchange Gain (Loss)	0.02	0	-0.04	-0.01	-0.01	0.07
Other Non Operating Income (Expenses)	-2.03	-2.13	0.01	-0.24	-0.02	-0.04
EBT Excluding Unusual Items	-2.31	-2.46	-0.3	-0.64	-1.02	-1.2
Asset Writedown	-	-	-	-	-0.35	-
Other Unusual Items	0.06	0.06	-	-	-	0.46
Pretax Income	-2.25	-2.4	-0.3	-0.64	-1.36	-0.74
Income Tax Expense	0.83	0.83	-	-	-	-
Earnings From Continuing Operations	-3.08	-3.23	-0.3	-0.64	-1.36	-0.74
Minority Interest in Earnings	0.02	0.02	0.03	0.02	0.01	-0.23
Net Income	-3.06	-3.21	-0.27	-0.62	-1.35	-0.97
Net Income to Common	-3.06	-3.21	-0.27	-0.62	-1.35	-0.97
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	12	12	11	10	2	1
Shares Outstanding (Diluted)	12	12	11	10	2	1
Shares Change	0.67%	3.43%	12.24%	363.47%	100.98%	298.94%
EPS (Basic)	-0.26	-0.28	-0.02	-0.06	-0.63	-0.91
EPS (Diluted)	-0.26	-0.28	-0.02	-0.06	-0.63	-0.91
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
EBIT	-0.22	-0.26	-0.23	-0.35	-0.97	-0.87